HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

esophageal and vulval Leiomyomatosis with nephropathy

Also Known As:
Leiomyomatosis, esophageal and vulval, with nephropathy; ATS-DL; Alport Syndrome And Diffuse Leiomyomatosis; Alport syndrome with diffuse leiomyomatosis; DL-ATS; Diffuse Leiomyomatosis With Alport Syndrome; Diffuse leiomyomatosis in Alport syndrome
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Experts

1. Bruttini, Mirella: 1 article (05/2011)
2. Izzi, Claudia: 1 article (05/2011)
3. Manno, Carlo: 1 article (05/2011)
4. Marcocci, Elena: 1 article (05/2011)
5. Mari, Francesca: 1 article (05/2011)
6. Meloni, Ilaria: 1 article (05/2011)
7. Mucciolo, Mafalda: 1 article (05/2011)
8. Renieri, Alessandra: 1 article (05/2011)
9. Salviati, Leonardo: 1 article (05/2011)
10. Scolari, Francesco: 1 article (05/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to esophageal and vulval Leiomyomatosis with nephropathy:
1. PseudoephedrineFDA LinkGeneric
2. N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
3. Phenylpropanolamine (Dexatrim)FDA Link
4. Methamphetamine (Desoxyn)FDA LinkGeneric
5. EphedrineFDA LinkGeneric
6. CollagenIBA
7. Amphetamine (Amfetamine)FDA LinkGeneric
8. norpseudoephedrine (cathine)IBA

Therapies and Procedures

1. Ligation